Ticker Scout
← tickerscout.ai

Becton, Dickinson and Company (BDX) Financials

CIK 0000010795 · NYSE · Latest period: Q3 FY2026 (ended 2026-06-30, 10-Q accession 0000010795-26-000035) · Annual report: FY2025 10-K (filed 2025-11-25, accession 0000010795-25-000099) · Next expected filing: 10-K ~2026-11-24

PeriodQ3 FY2026

Published

Becton Dickinson reported revenue from continuing operations of $4.98 billion for Q3 FY2026, the quarter ended June 30, 2026, up 5.4% from a year earlier, in its first full quarter after separating its Biosciences and Diagnostic Solutions business and combining it with Waters Corporation. Net income was $377 million, down 34.3% from $574 million, and diluted EPS was $1.37, compared with $2.00, because discontinued operations posted a loss of $74 million against income of $123 million a year earlier. Net income from continuing operations was $451 million, flat from a year earlier, and diluted EPS from continuing operations was $1.64, up 4.5% on a smaller diluted share count.

MetricAmountvs. year ago
Revenue$4,983,000,000up 5.4%
Net income$377,000,000down 34.3%
Diluted EPS$1.37down 31.5%
Net income from continuing operations$451,000,000flat
Diluted EPS from continuing operations$1.64up 4.5%
Discontinued operations, net of tax-$74,000,000swung from $123 million
Operating income$663,000,000down 10.3%

Company details

NameBecton Dickinson & Co
TickerBDX
CIK0000010795
ExchangeNYSE
StateNew Jersey
IncorporationNew Jersey
SIC3841
OfficeIndustrial Applications and Services
IndustrySurgical & Medical Instruments & Apparatus
Latest period coveredQ3 FY2026, ended 2026-06-30, 10-Q, accession 0000010795-26-000035
Fiscal year end09/30 (MM/DD)
Next expected filing10-K around 2026-11-24 (predicted)

Data files

  • Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included, plus a figure_sources block linking each figure the filing tags to the line that prints it.
  • 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
  • 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.

FAQ · Becton, Dickinson Q3 FY2026

How much revenue did Becton Dickinson report in Q3 FY2026?

Becton Dickinson reported revenue from continuing operations of $4.98 billion for Q3 FY2026, the quarter ended June 30, 2026, up 5.4% from $4.73 billion in the same quarter a year earlier. Both figures exclude the Biosciences and Diagnostic Solutions business that BD separated and combined with Waters Corporation, with the prior-year quarter recast on the same basis.

Why did Becton Dickinson's net income fall in Q3 FY2026?

Becton Dickinson's net income was $377 million in Q3 FY2026, compared with $574 million a year earlier, because discontinued operations posted a loss of $74 million, mainly foreign taxes associated with the separation of its Biosciences and Diagnostic Solutions business, against income of $123 million in the prior-year quarter. Net income from continuing operations was $451 million, flat from a year earlier.

What was Becton Dickinson's diluted EPS in Q3 FY2026?

Becton Dickinson reported diluted earnings per share of $1.37 for Q3 FY2026, compared with $2.00 a year earlier. Diluted EPS from continuing operations was $1.64, up 4.5% from $1.57, as a smaller diluted share count spread net income from continuing operations that was flat from a year earlier.

How did Becton Dickinson's operating income change in Q3 FY2026?

Becton Dickinson's operating income was $663 million in Q3 FY2026, down 10.3% from $739 million a year earlier, because higher selling and administrative, research and development and other operating expenses, the last mostly costs of separating its Biosciences and Diagnostic Solutions business and legal charges, outweighed higher gross profit. Gross margin narrowed as tariffs, higher labor costs and charges tied to the El Paso Warning Letter weighed on it. Lower interest expense, higher other income and a lower tax provision offset the lower operating income, leaving net income from continuing operations at $451 million.

Where can I get Becton, Dickinson and Company (BDX) financial data in machine-readable form?

Ticker Scout publishes Becton, Dickinson and Company's financial statements as JSON at https://tickerscout.ai/bdx/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/bdx/narrative.md and https://tickerscout.ai/bdx/events.md. Becton, Dickinson and Company's SEC CIK is 0000010795. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.

When does Becton, Dickinson and Company (BDX) next file with the SEC?

Becton, Dickinson and Company (BDX) is expected to file its next Form 10-K with the SEC on or around November 24, 2026. That date is a projection rather than a company-announced date: it is derived from Becton, Dickinson and Company's own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q3 FY2026, the period ended 2026-06-30, SEC accession 0000010795-26-000035.

Related companies

See every covered company and its filings data.

How this page was built

This page was built from Becton, Dickinson and Company's own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names six such gaps.

A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.

Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer

Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.